Prime Medicine, Inc.PRMENASDAQ
Loading
Enterprise value to sales ratio
5Y CAGR
-14.9%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 122.97 | +79.3% |
| 2024 | 68.60 | - |
| 2023 | 0.00 | - |
| 2022 | 0.00 | - |
| 2021 | 0.00 | -100.0% |
| 2020 | 275.32 | - |
| 2019 | 0.00 | - |